These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 10923546)

  • 1. Are there differences between vasodilating and nonvasodilating beta-blockers in patients with heart failure? Do patients with ischemic heart disease benefit to the same degree?
    Dickerson LM; Carek PJ
    J Fam Pract; 2000 Jun; 49(6):496, 571. PubMed ID: 10923546
    [No Abstract]   [Full Text] [Related]  

  • 2. Carvedilol or sustained-release metoprolol for congestive heart failure: a comparative effectiveness analysis.
    Shore S; Aggarwal V; Zolty R
    J Card Fail; 2012 Dec; 18(12):919-24. PubMed ID: 23207080
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Beta blockers in heart failure. Experiences and recommendations for clinical use. ANMCO-Area Heart Failure].
    Sinagra G; Boccanelli A; Camerini F; Gavazzi A; Gronda E; Maggioni AP; Opasich C; Rapezzi C; Scherillo M; Tavazzi L
    G Ital Cardiol; 1998 Jan; 28(1):61-70. PubMed ID: 9493048
    [No Abstract]   [Full Text] [Related]  

  • 4. The impact of beta-blockade on mortality rates in patients with congestive heart failure.
    Goldstein S; Gottlieb SS
    J Card Fail; 2000 Jun; 6(2 Suppl 1):15-24. PubMed ID: 10908094
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The COMET study compares effect of two different beta-blockers in chronic heart failure. Carvedilol better than metoprolol].
    Swedberg K
    Lakartidningen; 2003 Sep; 100(37):2852-4. PubMed ID: 14558169
    [No Abstract]   [Full Text] [Related]  

  • 6. Commentary on the Carvedilol or Metoprolol European Trial (COMET).
    Poole-Wilson PA
    Am J Cardiol; 2004 May; 93(9A):40B-2B. PubMed ID: 15144936
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Drug therapy of chronic heart failure: when are beta receptor blockers indicated?].
    vom Dahl J; Schotten U; Sasse A
    Dtsch Med Wochenschr; 1999 Sep; 124 Suppl 2():S48-53. PubMed ID: 10535047
    [No Abstract]   [Full Text] [Related]  

  • 8. [A randomized comparison of carvedilol and metoprolol in patients with chronic heart failure. The Carvedilol Or Metoprolol European Trial (COMET) ].
    Torp-Pedersen CT;
    Ugeskr Laeger; 2004 Aug; 166(32):2671-4. PubMed ID: 15347171
    [No Abstract]   [Full Text] [Related]  

  • 9. [A fairer comparison between carvedilol and metoprolol is still to be done].
    Johnsson G; Aberg J
    Lakartidningen; 2003 Oct; 100(44):3543-4, 3544-5. PubMed ID: 14651018
    [No Abstract]   [Full Text] [Related]  

  • 10. Major heart failure news from 2001.
    Francis D
    Heart Fail Monit; 2002; 2(4):147-8. PubMed ID: 12638556
    [No Abstract]   [Full Text] [Related]  

  • 11. [For the first time beta blockers are in direct comparison With carvedilol weak hearts beat longer].
    MMW Fortschr Med; 2003 Jul; 145(27-28):60. PubMed ID: 14587195
    [No Abstract]   [Full Text] [Related]  

  • 12. [Comparative study in heart failure. Which beta blocker saves more life time?].
    MMW Fortschr Med; 2003 Oct; 145(40):52. PubMed ID: 14603606
    [No Abstract]   [Full Text] [Related]  

  • 13. Beta blockers and congestive heart failure.
    Movahed A
    Am Fam Physician; 2000 Dec; 62(11):2402-4. PubMed ID: 11130228
    [No Abstract]   [Full Text] [Related]  

  • 14. Exchange of beta-blockers in heart failure patients. Experiences from the poststudy phase of COMET (the Carvedilol or Metoprolol European Trial).
    Di Lenarda A; Remme WJ; Charlesworth A; Cleland JG; Lutiger B; Metra M; Komajda M; Torp-Pedersen C; Scherhag A; Swedberg K; Poole-Wilson PA;
    Eur J Heart Fail; 2005 Jun; 7(4):640-9. PubMed ID: 15921806
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of metoprolol and carvedilol on cause-specific mortality and morbidity in patients with chronic heart failure--COMET.
    Torp-Pedersen C; Poole-Wilson PA; Swedberg K; Cleland JG; Di Lenarda A; Hanrath P; Komajda M; Lutiger B; Metra M; Remme WJ; Scherhag A; Skene A;
    Am Heart J; 2005 Feb; 149(2):370-6. PubMed ID: 15846279
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [COMET: metoprolol].
    Handa S
    Nihon Rinsho; 2007 Apr; 65 Suppl 4():521-5. PubMed ID: 17511103
    [No Abstract]   [Full Text] [Related]  

  • 17. Low-dose carvedilol improves left ventricular function and reduces cardiovascular hospitalization in Japanese patients with chronic heart failure: the Multicenter Carvedilol Heart Failure Dose Assessment (MUCHA) trial.
    Hori M; Sasayama S; Kitabatake A; Toyo-oka T; Handa S; Yokoyama M; Matsuzaki M; Takeshita A; Origasa H; Matsui K; Hosoda S;
    Am Heart J; 2004 Feb; 147(2):324-30. PubMed ID: 14760332
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Economic analysis of the treatment of heart failure with beta-blockers].
    Díez-Manglano J
    Med Clin (Barc); 2013 Sep; 141(6):265-70. PubMed ID: 23597957
    [No Abstract]   [Full Text] [Related]  

  • 19. Beta blockers in heart failure.
    Dargie HJ
    Lancet; 2003 Jul; 362(9377):2-3. PubMed ID: 12853188
    [No Abstract]   [Full Text] [Related]  

  • 20. Which beta-blocker for heart failure?
    Patel MR; Gattis W
    Am Heart J; 2004 Feb; 147(2):238. PubMed ID: 14760319
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.